Target intelligence / Profile preview

Nuclear receptor subfamily 2 group E member 3 (NR2E3)

Target
NR2E3
Molecular classification
Nuclear receptor superfamily, Intracellular transcription factor, Transcription factor
01

Overview

Nuclear hormone receptor subfamily 2 group E member 3 (NR2E3), also known as photoreceptor cell-specific nuclear receptor (PNR), is a photoreceptor-specific orphan nuclear hormone receptor that plays a critical role in the development and maintenance of retinal photoreceptors, particularly rods. It acts as both an activator and repressor in gene regulation. Mutations in NR2E3 are associated with several inherited retinal diseases, including Enhanced S-cone syndrome (ESCS), Goldmann-Favre syndrome, Retinitis pigmentosa, and Clumped pigmentary retinal degeneration (CPRD).

Other names
PNRPhotoreceptor cell-specific nuclear receptor
02

Mechanism of action

NR2E3 acts as both an activator and repressor in gene regulation, binding to promoter regions of rod and cone genes. It self-dimerizes into a default repressor state. Synthetic modulators can act as agonists, reverse agonists, or allosteric modulators.

03

Biological functions

Transcription regulationRod photoreceptor developmentCone photoreceptor repressionGene regulation
04

Disease associations

Enhanced S-cone syndrome (ESCS)Goldmann-Favre syndromeRetinitis pigmentosaClumped pigmentary retinal degeneration (CPRD)
05

Safety considerations

Clinical heterogeneity in NR2E3-related retinopathiesLimited genotype-phenotype correlation
06

Interacting drugs

13-cis retinoic acid

3 more in the full profile.

Beyond the preview

Go deeper on Nuclear receptor subfamily 2 group E member 3 (NR2E3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear receptor subfamily 2 group E member 3 (NR2E3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call